1. <ol id="xjlv9"><optgroup id="xjlv9"></optgroup></ol>
        <mark id="xjlv9"><acronym id="xjlv9"></acronym></mark>

        <samp id="xjlv9"><strong id="xjlv9"></strong></samp>

        免费观看国产短视频的方法_亚洲 日韩 欧美 成人 在线观看_思思久久96热在精品国产_亚洲中文无码mv

        ?
        生物資訊

        采取細(xì)胞因子療法可增強(qiáng)NK細(xì)胞殺傷腫瘤細(xì)胞能力

        作者:admin 來源:jci 發(fā)布時(shí)間: 2014-10-27 10:27  瀏覽次數(shù):
        購買進(jìn)口儀器、試劑和耗材——就在始于2001年的畢特博生物 effectnews.cn

         JCI:細(xì)胞因子療法增強(qiáng)NK細(xì)胞殺傷腫瘤細(xì)胞能力

        自然殺傷細(xì)胞(NK,natural killer cell)是免疫系統(tǒng)中的哨兵,可以快速響應(yīng)并殺死病變細(xì)胞。NK細(xì)胞是能針對(duì)和消除表面缺乏蛋白MHC I類的細(xì)胞,然而許多腫瘤細(xì)胞缺少這種蛋白,能抵抗NK細(xì)胞的監(jiān)視和殺傷。

        在Journal of Clinical Investigation雜志上的一項(xiàng)新研究顯示,細(xì)胞因子治療能增強(qiáng)NK細(xì)胞殺傷缺乏MHC I類腫瘤細(xì)胞的能力。

        利用小鼠模型,加州大學(xué)伯克利分校David Raulet確定,缺乏MHC-I類的腫瘤細(xì)胞會(huì)滅活nk細(xì)胞。

        由MHC I類陽性腫瘤細(xì)胞和MHC I類陰性腫瘤細(xì)胞組成的混合瘤也會(huì)引起NK細(xì)胞變得無響應(yīng)。重要的是,治療MHC I類缺陷的腫瘤小鼠,用細(xì)胞因子IL-12和IL-18或突變形式的IL-2可恢復(fù)NK細(xì)胞活性,減少腫瘤大小,并增加小鼠存活。

        這項(xiàng)研究的調(diào)查結(jié)果支持細(xì)胞因子治療或許可用于治療腫瘤細(xì)胞缺乏MHC I類的患者。

        原文標(biāo)題:Cytokine therapy reverses NK Cell anergy in MHC-deficient tumors

        原文摘要:Various cytokines have been evaluated as potential anticancer drugs; however, most cytokine trials have shown relatively low efficacy. Here, we found that treatments with IL-12 and IL-18 or with a mutant form of IL-2 (the “superkine” called H9) provided substantial therapeutic benefit for mice specifically bearing MHC class I–deficient tumors, but these treatments were ineffective for mice with matched MHC class I+ tumors. Cytokine efficacy was linked to the reversal of the anergic state of NK cells that specifically occurred in MHC class I–deficient tumors, but not MHC class I+ tumors. NK cell anergy was accompanied by impaired early signal transduction and was locally imparted by the presence of MHC class I–deficient tumor cells, even when such cells were a minor population in a tumor mixture. These results demonstrate that MHC class I–deficient tumor cells can escape from the immune response by functionally inactivating NK cells, and suggest cytokine-based immunotherapy as a potential strategy for MHC class I–deficient tumors. These results suggest that such cytokine therapies would be optimized by stratification of patients. Moreover, our results suggest that such treatments may be highly beneficial in the context of therapies to enhance NK cell functions in cancer patients.

        原文地址:http://www.jci.org/articles/view/74337 DOI:10.1172/JCI74337

         

         

        胚胎冷凍儀  程序降溫儀 (點(diǎn)擊標(biāo)題進(jìn)入)

        MP王牌產(chǎn)品- FastDNA土壤樣品提取試劑盒買五送禮品 (點(diǎn)擊標(biāo)題進(jìn)入)

        細(xì)胞治療使用的 lonza 04-418Q 無血清培養(yǎng)基 (點(diǎn)擊標(biāo)題進(jìn)入)

        專業(yè)有效的細(xì)胞離心涂片系統(tǒng)--Tharmac® Cellspin 載玻片離心機(jī)  點(diǎn)擊進(jìn)入)

        lonza 無血清培養(yǎng)基   (點(diǎn)擊標(biāo)題進(jìn)入)

        干細(xì)胞治療使用的 lonza 12-725F 無血清培養(yǎng)基 (點(diǎn)擊標(biāo)題進(jìn)入)

        購買進(jìn)口儀器、試劑和耗材——就在始于2001年的畢特博生物 effectnews.cn

        所有試劑均用于科研 ???? 北京畢特博生物技術(shù)有限責(zé)任公司 版權(quán)所有
        服務(wù)熱線:010-82015225/400-833-9299 | 傳真:010-62015131 | E-mail:info@bitebo.com
        京ICP備05028556號(hào)-1 ??京公網(wǎng)安備11010802008747??

        亚洲 日韩 欧美 成人 在线观看_思思久久96热在精品国产_亚洲中文无码mv_国产成本人片免费av_黄瓜视频在线观看

          1. <ol id="xjlv9"><optgroup id="xjlv9"></optgroup></ol>
            <mark id="xjlv9"><acronym id="xjlv9"></acronym></mark>

            <samp id="xjlv9"><strong id="xjlv9"></strong></samp>